Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Oct 27;289(6452):1136–1139. doi: 10.1136/bmj.289.6452.1136

Halothane anaesthesia and liver damage.

J Neuberger, R Williams
PMCID: PMC1443272  PMID: 6435802

Full text

PDF
1136

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Böttiger L. E., Dalén E., Hallén B. Halothane-induced liver damage: an analysis of the material reported to the Swedish Adverse Drug Reaction Committee, 1966-1973. Acta Anaesthesiol Scand. 1976;20(1):40–46. doi: 10.1111/j.1399-6576.1976.tb05007.x. [DOI] [PubMed] [Google Scholar]
  2. Canalese J., Wyke R. J., Vergani D., Eddleston A. L., Williams R. Circulating immune complexes in patients with fulminant hepatic failure. Gut. 1981 Oct;22(10):845–848. doi: 10.1136/gut.22.10.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carmichael F. J. Mechanism of liver necrosis in hyperthyroid rats. Anesthesiology. 1983 Dec;59(6):591–592. doi: 10.1097/00000542-198312000-00025. [DOI] [PubMed] [Google Scholar]
  4. Cousins M. J., Sharp J. H., Gourlay G. K., Adams J. F., Haynes W. D., Whitehead R. Hepatotoxicity and halothane metabolism in an animal model with application for human toxicity. Anaesth Intensive Care. 1979 Feb;7(1):9–24. doi: 10.1177/0310057X7900700102. [DOI] [PubMed] [Google Scholar]
  5. Duvaldestin P., Mazze R. I., Nivoche Y., Desmonts J. M. Occupational exposure to halothane results in enzyme induction in anesthetists. Anesthesiology. 1981 Jan;54(1):57–60. doi: 10.1097/00000542-198101000-00011. [DOI] [PubMed] [Google Scholar]
  6. Fee J. P., Black G. W., Dundee J. W., McIlroy P. D., Johnston H. M., Johnston S. B., Black I. H., McNeill H. G., Neill D. W., Doggart J. R. A prospective study of liver enzyme and other changes following repeat administration of halothane and enflurane. Br J Anaesth. 1979 Dec;51(12):1133–1141. doi: 10.1093/bja/51.12.1133. [DOI] [PubMed] [Google Scholar]
  7. Gottlieb L. S., Trey C. The effects of fluorinated anesthetics on the liver and kidneys. Annu Rev Med. 1974;25:411–429. doi: 10.1146/annurev.me.25.020174.002211. [DOI] [PubMed] [Google Scholar]
  8. Greene N. M. Halothane anesthesia and hepatitis in a high-risk population. N Engl J Med. 1973 Aug 9;289(6):304–307. doi: 10.1056/NEJM197308092890607. [DOI] [PubMed] [Google Scholar]
  9. Inman W. H., Mushin W. W. Jaundice after repeated exposure to halothane: a further analysis of reports to the Committee on Safety of Medicines. Br Med J. 1978 Nov 25;2(6150):1455–1456. doi: 10.1136/bmj.2.6150.1455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Johnston C. I., Mendelsohn F. Halothane hepatitis in a laboratory technician. Aust N Z J Med. 1971 May;1(2):171–173. doi: 10.1111/j.1445-5994.1971.tb02285.x. [DOI] [PubMed] [Google Scholar]
  11. Joshi P. H., Conn H. O. The syndrome of methoxyflurane-associated hepatitis. Ann Intern Med. 1974 Mar;80(3):395–401. doi: 10.7326/0003-4819-80-3-395. [DOI] [PubMed] [Google Scholar]
  12. Kaplan H. G., Bakken J., Quadracci L., Schubach W. Hepatitis caused by halothane sniffing. Ann Intern Med. 1979 May;90(5):797–798. doi: 10.7326/0003-4819-90-5-797. [DOI] [PubMed] [Google Scholar]
  13. Lewis J. H., Zimmerman H. J., Ishak K. G., Mullick F. G. Enflurane hepatotoxicity. A clinicopathologic study of 24 cases. Ann Intern Med. 1983 Jun;98(6):984–992. doi: 10.7326/0003-4819-98-6-984. [DOI] [PubMed] [Google Scholar]
  14. Lund I., Skulberg A., Helle I. Letter: Occupational hazard of halothane. Lancet. 1974 Aug 31;2(7879):528–528. doi: 10.1016/s0140-6736(74)92058-3. [DOI] [PubMed] [Google Scholar]
  15. Maiorino R. M., Sipes I. G., Gandolfi A. J., Brown B. R., Jr Quantitative analysis of volatile halothane metabolites in biological tissues by gas chromatography. J Chromatogr. 1979 Sep 11;164(1):63–72. doi: 10.1016/s0378-4347(00)81572-8. [DOI] [PubMed] [Google Scholar]
  16. Mieli-Vergani G., Vergani D., Tredger J. M., Eddleston A. L., Davis M., Williams R. Lymphocyte cytotoxicity to halothane altered hepatocytes in patients with severe hepatic necrosis following halothane anaesthesia. J Clin Lab Immunol. 1980 Jul;4(1):49–51. [PubMed] [Google Scholar]
  17. Morré D. J., Kartenbeck J., Franke W. W. Membrane flow and intercoversions among endomembranes. Biochim Biophys Acta. 1979 Apr 23;559(1):71–52. doi: 10.1016/0304-4157(79)90008-x. [DOI] [PubMed] [Google Scholar]
  18. Moult P. J., Sherlock S. Halothane-related hepatitis. A clinical study of twenty-six cases. Q J Med. 1975 Jan;44(173):99–114. [PubMed] [Google Scholar]
  19. Mushin W. W., Rosen M., Jones E. V. Post-halothane jaundice in relation to previous administration of halothane. Br Med J. 1971 Jul 3;3(5765):18–22. doi: 10.1136/bmj.3.5765.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nastainczyk W., Rendic S., Ullrich V., Krüger R. Hemmung Halothan-induzierter Leberzellnekrosen bei Ratten durch Metyrapon. Anaesthesist. 1982 Apr;31(4):181–184. [PubMed] [Google Scholar]
  21. Neuberger J., Gimson A. E., Davis M., Williams R. Specific serological markers in the diagnosis of fulminant hepatic failure associated with halothane anaesthesia. Br J Anaesth. 1983 Jan;55(1):15–19. doi: 10.1093/bja/55.1.15. [DOI] [PubMed] [Google Scholar]
  22. Neuberger J., Mieli-Vergani G., Tredger J. M., Davis M., Williams R. Oxidative metabolism of halothane in the production of altered hepatocyte membrane antigens in acute halothane-induced hepatic necrosis. Gut. 1981 Aug;22(8):669–672. doi: 10.1136/gut.22.8.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Neuberger J., Vergani D., Mieli-Vergani G., Davis M., Williams R. Hepatic damage after exposure to halothane in medical personnel. Br J Anaesth. 1981 Nov;53(11):1173–1177. doi: 10.1093/bja/53.11.1173. [DOI] [PubMed] [Google Scholar]
  24. Nunez-Gornes J. F., Marx J. J., Jr, Motszko C. Leukocyte migration inhibition in halothane-induced hepatitis. Clin Immunol Immunopathol. 1979 Sep;14(1):30–34. doi: 10.1016/0090-1229(79)90122-3. [DOI] [PubMed] [Google Scholar]
  25. Paronetto F., Popper H. Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. N Engl J Med. 1970 Aug 6;283(6):277–280. doi: 10.1056/NEJM197008062830602. [DOI] [PubMed] [Google Scholar]
  26. Pessayre D., Bentata M., Degott C., Nouel O., Miguet J. P., Rueff B., Benhamou J. P. Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction. Gastroenterology. 1977 Feb;72(2):284–289. [PubMed] [Google Scholar]
  27. Pohl L. R., Gillette J. R. A perspective on halothane-induced hepatotoxicity. Anesth Analg. 1982 Oct;61(10):809–811. [PubMed] [Google Scholar]
  28. Price C. D., Gibbs A. R., Williams W. J. Halothane macrophage migration inhibtiion factor test in halothane-associated hepatitis. J Clin Pathol. 1977 Apr;30(4):312–316. doi: 10.1136/jcp.30.4.312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Reynolds E. S., Moslen M. T. Halothane hepatotoxicity: enhancement by polychlorinated biphenyl pretreatment. Anesthesiology. 1977 Jul;47(1):19–27. [PubMed] [Google Scholar]
  30. Sharpstone P., Medley D. R., Williams R. Halothane hepatitis--a preventable disease? Br Med J. 1971 Feb 20;1(5746):448–450. doi: 10.1136/bmj.1.5746.448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Shingu K., Eger E. I., 2nd, Johnson B. H. Hypoxia may be more important than reductive metabolism in halothane-induced hepatic injury. Anesth Analg. 1982 Oct;61(10):824–827. [PubMed] [Google Scholar]
  32. Sipes I. G., Brown B. R., Jr An animal model of hepatotoxicity associated with halothane anesthesia. Anesthesiology. 1976 Dec;45(6):622–628. doi: 10.1097/00000542-197612000-00005. [DOI] [PubMed] [Google Scholar]
  33. Trowell J., Peto R., Smith A. C. Controlled trial of repeated halothane anaesthetics in patients with carcinoma of the uterine cervix treated with radium. Lancet. 1975 Apr 12;1(7911):821–824. [PubMed] [Google Scholar]
  34. Uetrecht J., Wood A. J., Phythyon J. M., Wood M. Contrasting effects on halothane hepatotoxicity in the phenobarbital-hypoxia and triiodothyronine model: mechanistic implications. Anesthesiology. 1983 Sep;59(3):196–201. [PubMed] [Google Scholar]
  35. Van Dyke R. A. Hepatic centrilobular necrosis in rats after exposure to halothane, enflurane, or isoflurane. Anesth Analg. 1982 Oct;61(10):812–819. [PubMed] [Google Scholar]
  36. Vergani D., Tsantoulas D., Eddleston A. L., Davis M., Williams R. Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anaesthesia. Lancet. 1978 Oct 14;2(8094):801–803. doi: 10.1016/s0140-6736(78)92585-0. [DOI] [PubMed] [Google Scholar]
  37. Walton B., Dumonde D. C., Williams C., Jones D., Strunin J. M., Layton J. M., Strunin L., Simpson R. Lymphocyte transformation. Absence of increased responses in alleged halothane jaundice. JAMA. 1973 Jul 30;225(5):494–498. doi: 10.1001/jama.225.5.494. [DOI] [PubMed] [Google Scholar]
  38. Walton B., Hamblin A., Dumonde D. C., Simpson R. Absence of cellular hypersensitivity in patients with unexplained hepatitis following halothane. Anesthesiology. 1976 May;44(5):391–397. doi: 10.1097/00000542-197605000-00007. [DOI] [PubMed] [Google Scholar]
  39. Walton B., Simpson B. R., Strunin L., Doniach D., Perrin J., Appleyard A. J. Unexplained hepatitis following halothane. Br Med J. 1976 May 15;1(6019):1171–1176. doi: 10.1136/bmj.1.6019.1171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Wei W. Z., Lindquist R. R. Local activation of the killing mechanism in PU5 antibody-dependent cell-mediated cytotoxicity effector cells. J Immunol. 1983 Mar;130(3):1458–1461. [PubMed] [Google Scholar]
  41. Williams B. D., White N., Amlot P. L., Slaney J., Toseland P. A. Circulating immune complexes after repeated halothane anaesthesia. Br Med J. 1977 Jul 16;2(6080):159–162. doi: 10.1136/bmj.2.6080.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wood M., Berman M. L., Harbison R. D., Hoyle P., Phythyon J. M., Wood A. J. Halothane-induced hepatic necrosis in triiodothyronine-pretreated rats. Anesthesiology. 1980 Jun;52(6):470–476. doi: 10.1097/00000542-198006000-00003. [DOI] [PubMed] [Google Scholar]
  43. Zauder H. L. A possible interaction of PCB and halothane in man. Anesthesiology. 1979 Jul;51(1):95–96. doi: 10.1097/00000542-197907000-00027. [DOI] [PubMed] [Google Scholar]
  44. de Groot H., Noll T. Halothane hepatotoxicity: relation between metabolic activation, hypoxia, covalent binding, lipid peroxidation and liver cell damage. Hepatology. 1983 Jul-Aug;3(4):601–606. doi: 10.1002/hep.1840030421. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES